Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Pulmonary Arterial Hypertension: Diagnosis and Evidence-Based Treatment
    Pulmonary Arterial Hypertension: Diagnosis and Evidence-Based Treatment
    Pulmonary Arterial Hypertension: Diagnosis and Evidence-Based Treatment
    Ebook230 pages5 hours

    Pulmonary Arterial Hypertension: Diagnosis and Evidence-Based Treatment

    ()

    Read preview

    About this ebook

    • First book dedicated to this disease, previously thought to be incurable, but with the advent of new drugs, now amenable to management and a much improved prognosis for patients
    • From the PAH Association, the leading experts in field
    • Incorporates the latest AACP management guidelines
    • Includes evidence-based treatment algorithms based on the recently updated ACCP Guidelines for Medical Treatment
    • Aimed at specialists in pulmonology and cardiovascular disease, this volume provides the clinician with the most up to date information on the effective management of PAH
    LanguageEnglish
    PublisherWiley
    Release dateSep 15, 2008
    ISBN9780470997383
    Pulmonary Arterial Hypertension: Diagnosis and Evidence-Based Treatment

    Related to Pulmonary Arterial Hypertension

    Related ebooks

    Related podcast episodes

    Related articles

    • Article

      Coronavirus Drug &Treatment Tracker

      Nov 6, 2020

      Coronavirus Drug &Treatment Tracker
      13 min read

    • Article

      Lung Transplantation for COVID-19-Associated Acute Respiratory Distress Syndrome in a PCR-Positive Patient

      Nov 6, 2020

      Most patients with COVID-19 have a mild or asymptomatic disease course; however, about 10% require admission to an intensive care unit (ICU) because of acute respiratory distress syndrome (ARDS).1,2 Mortality rates of up to 60% have been reported for

      10 min read

    • Article

      Negative Pressure Pulmonary Oedema/Haemorrhage

      Mar 1, 2022

      1 Specialist Physician (Intensivist), Aster Al Raffah Hospital, Muscat, Oman. 2 Specialist General Surgeon, Aster Al Raffah Hospital, Muscat, Oman. 3 Specialist Anaesthesiologist, Aster Al Raffah Hospital, Muscat, Oman. Negative pressure pulmonary oe

      7 min read

    • Article

      Amarin’s Vascepa Prevents Second And Third Heart Attacks In Analysis, Fueling Debate

      Mar 18, 2019

      A fish-oil-derived drug sold by Amarin Pharmaceuticals helped prevent not only initial cardiovascular events but also second and third heart attacks, according to a new analysis. #ACC19

      3 min read

    • Article

      Cutting To The Chase

      Feb 7, 2021

      Cutting To The Chase
      3 min read

    • Article

      Clinical Trials Find No Increase in Mortality Among COVID-19 Patients Treated with Remdesivir, Contrary to Viral Claim

      Apr 6, 2022

      Remdesivir is the only antiviral medication approved by the Food and Drug Administration to treat COVID-19. But a retired chiropractor misleadingly claims on a viral clip on social media that the drug is "killing people." Studies have shown that remd

      6 min read

    • Article

      Hyperthermia Studies

      Sep 24, 2023

      Von Ardenne was the first to use and systematically Clinical trials,1 including randomized controlled trials, considered the gold standard of scientific evidence, have reported positive outcomes when hyperthermia was used as an add-on treatment for c

      1 min read

    • Article

      Fish Oil Is Good! No, Bad! No, Good! No, Wait …

      Aug 5, 2022

      At first, it was all very exciting. In 1971, a team of Danish researchers stationed on Greenland’s northwest coast found that a local Inuit community had remarkably low levels of diabetes and heart disease. The reason, the researchers surmised, was t

      6 min read

    • Article

      Evidence Still Lacking to Support Ivermectin as Treatment for COVID-19

      Mar 14, 2022

      Randomized controlled trials haven't found ivermectin is beneficial in treating COVID-19, although results for ongoing studies will provide a more definitive answer. Yet, a video presents two weak studies as “powerful” and “overwhelming” evidence tha

      12 min read

    • Article

      Blood Test May Offer Better Heart Attack Prediction

      Jun 21, 2018

      A new blood test improves the prediction of the long-term risk of heart attack in people with severe coronary artery disease. In coronary artery disease, the arteries carrying oxygen-rich blood away from the heart become clogged with fatty plaque. Th

      3 min read

    • Article

      IV Iron Therapy May Benefit Patients With Heart Failure And Iron Deficiency

      Aug 28, 2023

      An intravenous iron treatment provides a measure of benefit to people with heart failure who have iron deficiency, a new study shows, but the results are nuanced. More than half of all patients with heart failure experience iron deficiency, which is

      1 min read

    • Article

      Living Donor Liver Transplantation for Acute Liver Failure Due to Hepatitis E in a Pregnant Patient - Challenges in Management

      Jul 30, 2020

      Dr Rakesh Babu, Senior Specialist, Anesthesia and Intensive Care, Aster MIMS, Kozhikode, Kerala, india Hepatitis E virus belonging to the family Hepeviridae, is an important cause of enterically transmitted hepatitis in the developing countries. Hepa

      5 min read

    • Article

      2 Anti-inflammatory Drugs Prevented COVID Deaths

      Jul 11, 2023

      Two anti-inflammatory drugs didn’t shorten recovery time for patients hospitalized with severe COVID-19, but did reduce the likelihood of death, a new study shows. The researchers compared patients who received the drugs, commonly prescribed to treat

      3 min read

    • Article

      Cancer Drug May Treat Severe Asthma

      May 22, 2017

      A small clinical trial suggests that some patients with severe asthma may benefit from treatment with a targeted cancer drug. The findings show that imatinib (brand name Gleevec), commonly prescribed to treat chronic myeloid leukemia, also targets sp

      2 min read

    Related categories

    Reviews for Pulmonary Arterial Hypertension

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words

      Book preview

      Pulmonary Arterial Hypertension - Robyn Barst

      Gdbook_preview_excerpt.html
      Enjoying the preview?
      Page 1 of 1